Drug intelligence / Profile preview

fentanyl + droperidol

Development stage
Unknown
Lead developer
Janssen Pharmaceutica
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

This drug is a fixed combination of two active pharmaceutical ingredients—fentanyl, a highly potent synthetic opioid analgesic, and droperidol, a butyrophenone derivative antipsychotic with dopamine antagonist properties. The combination is primarily used to induce neuroleptanalgesia—a state characterized by profound sedation (tranquilization), analgesia (pain relief), and indifference to surroundings while maintaining the ability to cooperate with medical staff. Fentanyl acts as an agonist at the mu-opioid receptor, providing rapid-onset pain relief and sedation. Droperidol acts mainly as an antagonist at dopamine D2 receptors in the central nervous system, producing tranquilization and antiemetic effects. This combination has been used for anesthesia adjunct during surgical or diagnostic procedures, especially in otorhinolaryngological surgery and for management of equilibratory disturbances such as those seen in Meniere's syndrome[1][3][8]. Both drugs were originally synthesized by Janssen Pharmaceutica.

Brand names
InnovaR
Other names
droperidol and fentanyl citratedroperidol/fentanyl
02

Targets

KOR (Kappa opioid receptor)HTR2A (Serotonin receptor 5-HT2A)MOR (Mu opioid receptor)ADRA1A (α1A)DRD2 (Dopamine D2 Receptor)DOR (Opioid Receptor Delta 1)

Beyond the preview

Go deeper on fentanyl + droperidol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fentanyl + droperidol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call